Effectiveness of stress inoculation training approach on premenstrual syndrome

Not Applicable

Conditions: Anxiety and depression.
Mixed anxiety and depressive disorder
F41.2

Registration Number: IRCT20230130057274N2

Lead Sponsor: Babol University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 100

Inclusion Criteria

Being Iranian
Students living in the student dormitory of Babol University of Medical Sciences
Declaration of consent to participate in the study
Having premenstrual syndrome
Having regular menstrual cycles with intervals of 21 to 35 days and a duration of 3 to 7 days at least during the last six months
Having 5 symptoms of premenstrual syndrome for two consecutive months
Having symptoms of depression or anxiety with a score of 8 or higher
Access to the smartphone
Age range from 18 to 38 years

Exclusion Criteria

Use of antidepressants and anxiety medications during the study
Participation in other psychological interventions such as psychotherapy, meditation, yoga
Occurrence of stressful events at least six months before the start of the study
Suffering from genital diseases and known and chronic underlying diseases
Taking birth control pills
Hormonal disorders and irregular menstruation
Current or history of severe mental illness such as severe depression, bipolar disorder, and suicidal thoughts
Drug addiction and consumption of psychoactive substances or alcohol

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety. Timepoint: Before the intervention, immediately after the end of the intervention in the luteal phase, the first and second menstrual cycle after the intervention. Method of measurement: Hospital anxiety and depression questionnaire.;Depression. Timepoint: Before the intervention, immediately after the end of the intervention in the luteal phase, the first and second menstrual cycle after the intervention. Method of measurement: Hospital anxiety and depression questionnaire.

Secondary Outcome Measures

Name	Time	Method
Stress. Timepoint: Before the intervention, immediately after the end of the intervention in the luteal phase, the first and second menstrual cycle after the intervention. Method of measurement: Perceived Stress Questionnaire 14.;Performance. Timepoint: Before the intervention, immediately after the end of the intervention in the luteal phase, the first and second menstrual cycle after the intervention. Method of measurement: Sheehan's Disability Questionnaire.;Psychological well-being. Timepoint: Before the intervention, immediately after the end of the intervention in the luteal phase, the first and second menstrual cycle after the intervention. Method of measurement: Riff's Psychological Well-Being Questionnaire.;Symptoms of premenstrual syndrome. Timepoint: Before the intervention, immediately after the end of the intervention in the luteal phase, the first and second menstrual cycle after the intervention. Method of measurement: Premenstrual Symptoms Screening Questionnaire.